USD 21.69
(-2.58%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 104.6 Million USD | 32.75% |
2022 | 78.8 Million USD | 238.27% |
2021 | 23.29 Million USD | 16.22% |
2020 | 20.04 Million USD | 0.0% |
2019 | - USD | -100.0% |
2018 | 2.1 Million USD | -9.63% |
2017 | 2.32 Million USD | -8.23% |
2016 | 2.53 Million USD | 368.47% |
2015 | 540.79 Thousand USD | -28.69% |
2014 | 758.34 Thousand USD | -31.75% |
2013 | 1.11 Million USD | -47.64% |
2012 | 2.12 Million USD | 249.69% |
2011 | 606.78 Thousand USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 500 Thousand USD | -31.18% |
2008 | 726.53 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | -100.0% |
2002 | 27.5 Thousand USD | -16.67% |
2001 | 33 Thousand USD | -15.38% |
2000 | 39 Thousand USD | -9.3% |
1999 | 43 Thousand USD | -86.19% |
1998 | 311.43 Thousand USD | 0.0% |
1997 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 336.03 Million USD | 19.61% |
2024 Q1 | 115.15 Million USD | 0.0% |
2024 Q2 | 280.93 Million USD | 0.0% |
2023 Q3 | 79.91 Million USD | -0.2% |
2023 Q2 | 80.07 Million USD | 0.76% |
2023 FY | 104.6 Million USD | 32.75% |
2023 Q1 | 79.47 Million USD | 0.85% |
2023 Q4 | 104.6 Million USD | 30.91% |
2022 Q1 | 22.48 Million USD | -3.46% |
2022 FY | 78.8 Million USD | 238.27% |
2022 Q4 | 78.8 Million USD | 0.73% |
2022 Q3 | 78.23 Million USD | 244.66% |
2022 Q2 | 22.69 Million USD | 0.93% |
2021 Q3 | 22.85 Million USD | 1.45% |
2021 Q4 | 23.29 Million USD | 1.93% |
2021 Q2 | 22.52 Million USD | 14.44% |
2021 FY | 23.29 Million USD | 16.22% |
2021 Q1 | 19.68 Million USD | -1.79% |
2020 Q3 | 20.35 Million USD | 43.59% |
2020 FY | 20.04 Million USD | 0.0% |
2020 Q1 | 14.37 Million USD | 0.0% |
2020 Q2 | 14.17 Million USD | -1.38% |
2020 Q4 | 20.04 Million USD | -1.55% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | -100.0% |
2019 FY | - USD | -100.0% |
2019 Q2 | - USD | 0.0% |
2018 Q2 | 2.21 Million USD | -2.44% |
2018 FY | 2.1 Million USD | -9.63% |
2018 Q3 | 2.15 Million USD | -2.55% |
2018 Q4 | 2.1 Million USD | -2.66% |
2018 Q1 | 2.27 Million USD | -2.34% |
2017 Q4 | 2.32 Million USD | -2.25% |
2017 FY | 2.32 Million USD | -8.23% |
2017 Q3 | 2.37 Million USD | -2.16% |
2017 Q2 | 2.43 Million USD | -2.08% |
2017 Q1 | 2.48 Million USD | -2.0% |
2016 Q2 | 430.66 Thousand USD | -11.36% |
2016 FY | 2.53 Million USD | 368.47% |
2016 Q4 | 2.53 Million USD | -14.47% |
2016 Q1 | 485.84 Thousand USD | -10.16% |
2016 Q3 | 2.96 Million USD | 587.82% |
2015 Q3 | 595.51 Thousand USD | -8.38% |
2015 FY | 540.79 Thousand USD | -28.69% |
2015 Q1 | 705.17 Thousand USD | -7.01% |
2015 Q4 | 540.79 Thousand USD | -9.19% |
2015 Q2 | 650.01 Thousand USD | -7.82% |
2014 Q3 | 812.16 Thousand USD | -6.19% |
2014 Q4 | 758.34 Thousand USD | -6.63% |
2014 FY | 758.34 Thousand USD | -31.75% |
2014 Q1 | 1 Million USD | -9.42% |
2014 Q2 | 865.77 Thousand USD | -13.97% |
2013 FY | 1.11 Million USD | -47.64% |
2013 Q1 | 1.27 Million USD | -39.78% |
2013 Q3 | 1.16 Million USD | -4.54% |
2013 Q4 | 1.11 Million USD | -4.79% |
2013 Q2 | 1.22 Million USD | -4.31% |
2012 FY | 2.12 Million USD | 249.69% |
2012 Q3 | 2.13 Million USD | -0.4% |
2012 Q1 | 2.14 Million USD | 253.84% |
2012 Q4 | 2.12 Million USD | -0.39% |
2012 Q2 | 2.13 Million USD | -0.39% |
2011 Q2 | 519.71 Thousand USD | 0.0% |
2011 Q4 | 606.78 Thousand USD | 8.19% |
2011 FY | 606.78 Thousand USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | 560.87 Thousand USD | 7.92% |
2010 Q1 | - USD | -100.0% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q4 | 500 Thousand USD | -13.02% |
2009 Q3 | 574.84 Thousand USD | -79.56% |
2009 Q1 | 3.03 Million USD | 317.06% |
2009 FY | 500 Thousand USD | -31.18% |
2009 Q2 | 2.81 Million USD | -7.17% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | 726.53 Thousand USD | 0.0% |
2008 FY | 726.53 Thousand USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q4 | - USD | -100.0% |
2003 FY | - USD | -100.0% |
2003 Q1 | 26 Thousand USD | -5.45% |
2003 Q2 | 27.5 Thousand USD | 5.77% |
2003 Q3 | 27.5 Thousand USD | 0.0% |
2002 FY | 27.5 Thousand USD | -16.67% |
2002 Q4 | 27.5 Thousand USD | -5.17% |
2002 Q2 | 30.5 Thousand USD | -4.69% |
2002 Q1 | 32 Thousand USD | -3.03% |
2002 Q3 | 29 Thousand USD | -4.92% |
2001 FY | 33 Thousand USD | -15.38% |
2001 Q1 | 37.5 Thousand USD | -3.85% |
2001 Q2 | 36 Thousand USD | -4.0% |
2001 Q4 | 33 Thousand USD | -4.35% |
2001 Q3 | 34.5 Thousand USD | -4.17% |
2000 Q3 | 40.5 Thousand USD | 3.85% |
2000 Q4 | 39 Thousand USD | -3.7% |
2000 FY | 39 Thousand USD | -9.3% |
2000 Q2 | 39 Thousand USD | -1.27% |
2000 Q1 | 39.5 Thousand USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 FY | 43 Thousand USD | -86.19% |
1998 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 FY | 311.43 Thousand USD | 0.0% |
1997 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 45.212% |
Codexis, Inc. | 12.24 Million USD | -754.431% |
Viridian Therapeutics, Inc. | 20.2 Million USD | -417.733% |
Organovo Holdings, Inc. | 888 Thousand USD | -11680.18% |